Astral Other Announcement

Astral Other Announcement

Astral Ltd has submitted its quarterly shareholding pattern in compliance with Regulation 31(1)(b) of the SEBI Listing Regulations for the quarter ended September 30, 2026.

Astral Annual General Meeting

Astral Limited held its 30th Annual General Meeting on August 24, 2026. Shareholders considered financial statements, dividends, and director re-appointments.

Astral Earnings Call Transcript: Key Takeaways

Astral delivered a robust 15.9% revenue growth and 15.5% consolidated EBITDA margin, significantly outperforming a sluggish polymer industry that contracted 10%. Growth was driven by adhesives and paints, despite flat plumbing volumes.

Call

Guides 20% growth

Astral Results Update

Astral Limited released its Q1 2026-27 financial highlights, reporting consolidated revenue growth of 15.9% and EBITDA growth of 25.8%. The update also provided business segment performance.

Astral Q1 FY27 Results: Net Profit ₹120.2 Cr, Up 51.8% YoY

Astral Ltd reported revenue from operations of ₹1,578 Cr (+15.9% YoY) and net profit of ₹120.2 Cr (+51.8% YoY) for Q1 FY27.

Key figure

Net profit ₹120.2 Cr · +51.8% YoY

Astral Board Meeting Date

Astral Limited will hold a board meeting on 12th August, 2026, to approve the company's unaudited financial results for the quarter ended 30th June, 2026.

Mahindra & Mahindra Financial Services Other Announcement

Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.

ACME Solar Holdings Other Announcement

ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.

eMudhra Other Announcement

eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.

Aarti Pharmalabs Other Announcement

Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.

Sagarsoft (India) Other Announcement

Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.

Sadhana Nitro Chem Other Announcement

Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.